Viking Thera VKTX

$29.94 -0.57 (-1.87%)

Valuation

Market cap
3,843,863,000
Revenue TTM
$0
Net income TTM
$-359,640,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
6,367,000
Avg volume
4,373,318
Day's range
$29.90 – $31.09
Shares out
125,987,000
Stochastic %K
0%
Beta
0.66
Analysts
Strong Sell
Price target
$92.00

Price

Company profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as...

Show more

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 704 4660
Website
https://www.vikingtherapeutics.com
Address
9920 Pacific Heights Boulevard, Suite 350, San Diego, United States

Latest news

Stocktwits

Rickerthestockpicker Oct 4, 12:01 AM
$VKTX I would settle for 90 - 100 per share Monday Morning or else I am still going to be holding forever
0 replies
JIMMYDAMA Oct 3, 9:51 PM
$VKTX Recent Sentiment is ripe for an Offer, a decent offer would temp many to vote YES, rather than endure 2 more years of manipulation! This drug in the hands of a Bigger Co is still going to change the acquiring company’s trajectory in a meaningful way! I would yes, there’s plenty of ways BL can screw this up before commercialization ! GLTAL
1 replies
Dovkav Oct 3, 9:47 PM
$TGE $VKTX $SECZ
0 replies
saifnila2 Oct 3, 9:42 PM
$VKTX everyone knows they can buy vikings today and become a powerhouse in the obesity market by 2028. There is nobody else that has such a powerful drug or is more advanced in the pathway to approval. All big pharma are aware of these facts , its a matter of time. Even brain can't stop a deal, he is only a 2 percent owner.
1 replies
Mommaxstocks90 Oct 3, 8:49 PM
$VKTX looks like it filled that gap from that run up last week and seems to be holding in the $30 dollar range for now, although a drop to 28 even less would be a blessing for those of us who weren’t aware of this stock prior to run up in my opinion. I definitely sold my shares after offering was announced to secure profit since I had a feeling this would dip to where it started. will be throwing in a decent amount Monday and plan to load up if it were to go any lower then 29 for sure. I believe in the long term it will pay out significantly. Stock has held up well based on charts prior to this, the medication has had excellent results consistently, high demand with weight loss, additionally with weight loss, can help people who have comorbities stemming from weight gain (HTN which can put risk for stroke/kidney disease, respiratory complications/sleep apnea, the list goes on) so if it has minimal side effects compared to others it will boom.
1 replies
Freakyguy666 Oct 3, 8:42 PM
$VKTX not sure what your point is…if he’s fired without cause the options still vest. And they have until MONDAY to file the 4k with Sec. RELAX! 🤣😂
1 replies
GPTInsights Oct 3, 7:51 PM
$SECZ $TGE $VKTX what is the point of this video? “uhh vktx straight down for like 7 days”. Nice analysis. Subscribe and like and join my patreon guys.
0 replies
charlesharvie Oct 3, 7:42 PM
$VKTX then they posted this one on a Saturday hahah…
2 replies